Clonal hematopoiesis and bone marrow inflammation. 2023

Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
School of Biomedical Sciences, Hunan University, Changsha, China.

Clonal hematopoiesis (CH) occurs in hematopoietic stem cells with increased risks of progressing to hematologic malignancies. CH mutations are predominantly found in aged populations and correlate with an increased incidence of cardiovascular and other diseases. Increased lines of evidence demonstrate that CH mutations are closely related to the inflammatory bone marrow microenvironment. In this review, we summarize the recent advances in this topic starting from the discovery of CH and its mutations. We focus on the most commonly mutated and well-studied genes in CH and their contributions to the innate immune responses and inflammatory signaling, especially in the hematopoietic cells of bone marrow. We also aimed to discuss the interrelationship between inflammatory bone marrow microenvironment and CH mutations. Finally, we provide our perspectives on the challenges in the field and possible future directions to help understand the pathophysiology of CH.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082182 Clonal Hematopoiesis Expansion of blood cells arising from mutant HEMATOPOIETIC STEM CELLS often related to aging. Mutations on epigenetic regulator genes are common in clonal hematopoiesis and may be a risk factor for HEMATOLOGIC NEOPLASMS and other cardiovascular diseases. When variant allele fraction is at least 2% and is present in the absence of severe cytopenias it is referred to as clonal hematopoiesis of indeterminate potential (CHIP). ARCH Age-related Clonal Hematopoiesis,Age-related Clonal Hematopoiesis,CCUS Clonal Cytopenia of Undetermined Significance,CHIP Clonal Hematopoiesis of Indeterminate Potential,Clonal Cytopenia of Undetermined Significance,Clonal Hematopoiesis of Indeterminate Potential,ICUS Idiopathic Cytopenias of Undetermined Significance,Idiopathic Cytopenias of Undetermined Significance,ARCH Age related Clonal Hematopoiesis,Age related Clonal Hematopoiesis,Clonal Hematopoiesis, Age-related,Hematopoiesis, Age-related Clonal,Hematopoiesis, Clonal
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D060965 Clonal Evolution The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION. Somatic Evolution,Evolution, Clonal,Evolution, Somatic

Related Publications

Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
December 1989, The New England journal of medicine,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
June 2021, Best practice & research. Clinical haematology,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
October 2020, Blood,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
May 2021, Journal of visualized experiments : JoVE,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
January 2024, Annual review of pathology,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
September 2016, Leukemia,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
April 2023, Nature communications,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
April 2024, Blood advances,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
August 2023, Trends in cell biology,
Xinshu Xie, and Meng Su, and Kehan Ren, and Xuezhen Ma, and Zhiyi Lv, and Zhaofeng Li, and Yang Mei, and Peng Ji
June 2023, The Journal of clinical investigation,
Copied contents to your clipboard!